Speech Path TechSpeech Path TechRegister interest
For Partners & Investors

A category-defining team reshaping a quietly massive industry.

Speech pathology in Australia is a multi-billion-dollar allied health category, powered by NDIS and telehealth, staffed by a workforce that overwhelmingly wants to go private — and served by software that hasn't caught up. Speech Path Tech is the platform built for how it actually works now.

$2.27B
AU speech pathology market by 2034
$2.17B
AU telehealth market by 2033
15,000+
SPA members
Pre-seed
raise open now
Weekly waitlist growth
Private beta
SPs
+30
Families
+80
States
1 → 2
Investor tour · 60 seconds
AU speech pathology TAM
$2.27B
Forecast by 2034
NDISTelehealthPaediatricAdult
market
The market

A quietly massive category — ready to be re-platformed.

Speech pathology is one of the largest allied-health verticals in Australia, growing on the back of NDIS, telehealth and a workforce that overwhelmingly wants to go private. It's underserved by software built for it.

  • AU speech pathology market: $2.27B by 2034
  • AU telehealth: $2.17B by 2033
  • 15,000+ SPA members and growing
Per-session model
Sessions
200
Take
$900
Stripe Connect · settled T+2
model
The business model

Transparent, per-session revenue.

We take a small per-session fee via Stripe Connect. No seat licences, no per-clinician SaaS lock-in. Revenue scales linearly with sessions delivered on the platform — a clean, defensible unit economic.

  • Per-session take rate via Stripe Connect
  • Two-sided flywheel: SPs bring clients, clients bring SPs
  • Expansion into intake, insurance and workforce
Waitlist growth
SPs
+30/wk
Families
+80/wk
traction
Traction & pipeline

Waitlist growth on both sides of the marketplace.

We're in private beta with speech professionals and families joining every week. Distribution is powered by SPA networks, NDIS communities and organic word of mouth in a tight-knit profession.

  • Growing waitlist on both sides
  • Deep integrations with NDIS workflows
  • Advisory support from senior clinicians
Founding team
JW
Jessica
Clinical + CEO
RC
Rebecca
Product
Pre-seed round open
team
The team & the ask

Female-led. Clinically-grounded. Building for scale.

A founding team blending clinical practice, product and engineering. We're raising to accelerate matching, expand the NDIS module and prove the model in a second Australian state before national rollout.

  • Clinician + product + engineering founders
  • Advisors across SPA, NDIS and health law
  • Currently raising a pre-seed round
Why now

Three shifts have quietly stacked in our favour.

NDIS at scale

Funding for speech pathology is embedded in a national scheme — with private providers doing the majority of the work.

Telehealth is normal

Post-2020, families and clinicians are comfortable with remote sessions — expanding the addressable geography overnight.

The workforce wants out

A predominantly female workforce is leaving traditional clinics for private practice — and needs a platform built for them.

Compliance by design

Aligned with the SPA Code of Ethics, Australian Privacy Principles, and NDIS Practice Standards.

Institutional-ready

Clean cap table, Stripe Connect payments, and structured advisory board across clinical and legal.

AU-first, globally applicable

The wedge is Australia. The pattern — clinician-led marketplaces with plan-funded care — travels.

This page is maintained by the Speech Path Tech team. Market figures are sourced from publicly available industry reports; specific investor materials, financial detail and diligence packs are shared under NDA on request.

Let's talk.

If you back founder-led, clinically-grounded software in real categories — we'd love to share our data room.

Register interest